Drugmaker Glenmark Pharmaceuticals clocked a consolidated ... Strengthening our value-chain strategy, we secured MHRA authorization for Winlevi in the UK, marking a pivotal step in expanding ...

Glenmark Pharmaceuticals Ltd reported a net profit of ₹347.9 crore for Q3 FY25 as compared to a net loss of ₹351.3 crore in the third quarter of last fiscal. Revenue from operations jumped ...

Feb 14 (Reuters) - India's Glenmark Pharmaceuticals (GLEN.NS), opens new tab reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

Glenmark Pharmaceuticals Ltd. is a research-led, global pharmaceutical company, having a presence across branded, generics, and OTC segments; with a focus on therapeutic areas of respiratory, ...

A collection of the most-viewed Moneycontrol videos. Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting ...

(Reuters) - India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs. The drugmaker reported a consolidated net ...

1 Glenmark's Clindamycin Phosphate Foam, 1% is only approved for the indication(s) listed in Glenmark's approved label. 2 All brand names and trademarks are the property of their respective owners.

Glenmark Pharmaceuticals reported a net profit of Rs 348 crore for Q3FY25, a significant turnaround from a Rs 351 crore loss ...

with the pharmaceutical industry particularly at risk due to an extensive and international supply chain. From chemicals to API manufacturing, formulation, packaging, and drug delivery to the ...

pharma must have visibility into partners’ manufacturing operations to track product quality across the multi-tier, multi-enterprise supply chain. This means connecting to their CMO’s ...